Cargando…
Risk factors for hematoma in patients undergoing cardiac device procedures: A WRAP-IT trial analysis
BACKGROUND: Implant site hematoma is a known complication of cardiac device procedures and can lead to major consequences. OBJECTIVES: To evaluate risk factors for hematoma and further understand the relationship between anticoagulant (AC), antiplatelet (AP) use, and hematoma development. METHODS: W...
Autores principales: | Tarakji, Khaldoun G., Korantzopoulos, Panagiotis, Philippon, Francois, Biffi, Mauro, Mittal, Suneet, Poole, Jeanne E., Kennergren, Charles, Lexcen, Daniel R., Lande, Jeff D., Hilleren, Gregory, Seshadri, Swathi, Wilkoff, Bruce L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9626743/ https://www.ncbi.nlm.nih.gov/pubmed/36340491 http://dx.doi.org/10.1016/j.hroo.2022.05.012 |
Ejemplares similares
-
849. Reduced CIED Infections with an Antibacterial Envelope: Microbiologic Analysis of the WRAP-IT Study
por: Sohail, Muhammad R, et al.
Publicado: (2019) -
Impact of Cardiac Implantable Electronic Device Infection: A Clinical and Economic Analysis of the WRAP-IT Trial
por: Wilkoff, Bruce L., et al.
Publicado: (2020) -
Cost-Effectiveness of an Antibacterial Envelope for Cardiac Implantable Electronic Device Infection Prevention in the US Healthcare System From the WRAP-IT Trial
por: Wilkoff, Bruce L., et al.
Publicado: (2020) -
Infections associated with cardiac electronic implantable devices: economic perspectives and impact of the TYRX™ antibacterial envelope
por: Boriani, Giuseppe, et al.
Publicado: (2021) -
Antibiotic eluting envelopes: evidence, technology, and defining high-risk populations
por: Callahan, Thomas D, et al.
Publicado: (2021)